Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on April 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

DEXTROSE AND SODIUM

Closed
SPE2DP-26-T-2824Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract pertains to the procurement of Dextrose and Sodium Chloride Injection, USP, specifically a sterile, nonpyrogenic intravenous solution containing 5% hydrous dextrose and 0.20% sodium chloride in 500 milliliter single-dose containers. Each unit is packaged as a package containing 24 single-dose containers. The product is FDA-regulated and must be stored at room temperature with brief tolerance for elevation up to 40°C, avoiding freezing and excessive heat. Labeling and marking requirements comply with Medical Marking Standard No. 1A from February 2013, superseding older military standards. The shelf life is fixed at 24 months and is not extendable. The packaging, both unit and exterior shipping containers, must protect against damage and ensure safe delivery at the lowest transportation rate to the designated destination. This solicitation is issued by the Department of Defense under the Medical Supply Chain Pharmaceutical FSA, with a requirement for delivery within five days to the destination specified. The purchase request includes two packages, each containing 24 units, with full adherence to DLA packaging and quality standards as outlined in the DLA master list of technical and quality requirements. The contractor must provide all sales and product details, including manufacturer information and part numbers, for confirmation by product specialists. The contract enforces strict inspection and acceptance points at the destination and mandates packaging in line with the latest medical and defense regulatory guidelines to ensure compliance and safe handling of the medical injection solution.

General Info

Procurement of FDA-regulated sterile Dextrose and Sodium Chloride Injection, 5%/0.2%, 24-month shelf life.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-2824.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts
Patrell Postell

Full Description

Show more
DEXTROSE AND SODIUM
DEXTROSE AND SODIUM CHLORIDE INJECTION,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. RX ONLY; STERILE AND NONPYROGENIC.. FOR INTRAVENOUS USE ONLY..
CONTAINER SIZE: 500 MILLILITERS (ML). EACH ML CONTAINS 5 GRAMS OF
HYDROUS DEXTROSE USP (5%) AND 0.2 GRAMS (0.20%) OF SODIUM CHLORIDE USP.
. UNIT OF ISSUE IS A PACKAGE CONTAINING 24 EACH (SINGLE DOSE
CONTAINERS).. IT IS RECOMMENDED THE PRODUCT BE STORED AT ROOM
TEMPERATURE (25°C); HOWEVER, BRIEF EXPOSURE UP TO 40°C DOES NOT
ADVERSELY AFFECT THE PRODUCT.. AVOID EXCESSIVE HEAT AND PROTECT FROM
FREEZING.. LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING
STANDARD NO. 1A DATED 4 FEBRUARY 2013. 2/22/2016..
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 24 EA RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
SPE2DP-26-T-2824
SECTION B
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
ICU MEDICAL SALES, INC. 85RR5 P/N NDC00990-7924-03
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016257328 0001 PG 2.000
NSN/MATERIAL:6505013724486
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-372-4486 Quantity: 2 PG Purchase Request: 7016257328QTY: 2 Delivery: 5 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS